FounderDeckPack

Crohn's AI

34
Signal
CA

Crohn's AI

crohns.ai
AIcrohns.ai

Crohn's AI — AI-guided support for living with Crohn's disease and IBD.

FounderDeck estimate
$170k
Valued 2026-08-20
Early Momentum 0 portfolios
View Crohn's AI company profile

Crohn's AI

Crohn's AI — AI-guided support for living with Crohn's disease and IBD.

crohns.ai

Is this your company?

Claim it to edit details, or request removal anytime.

Early MomentumUnclaimed ProfileAI NativeEarly DiscoveryEarly Build
FounderDeck estimate
$170k
Low confidenceValued Aug 20, 2026
0
Portfolios
Browse companies freely. New portfolio additions come exclusively from your daily pack.
B2B SaaSEarly traction
0
Momentum
0
Daily views
0
Pack saves

Momentum rises when people search, view, like, share, claim, or save this profile.

What it does

Crohn's AI — AI-guided support for living with Crohn's disease and IBD. FounderDeck captured this company from its public website and generated an early discovery profile from the product signals visible on the page.

Who it helps

Likely aimed at teams or operators using AI to automate workflows, speed up output, or unlock a new capability.

Why it's interesting

Crohn's AI shows a live product footprint, a visible market angle, and enough public signal to be worth tracking early on FounderDeck.

Profile signals

Signal Score34
Product Clarity24
Founder Momentum34
Market Potential39
Website Polish42
Monetisation39
Shareability41
Buzz46

AI-assisted scores estimated from public website information only.

FounderDeck estimate

Low confidence
$170k

FounderDeck estimated this early value from the public website, product clarity, market shape, monetisation cues, and overall signal strength visible on the page.

Valuation date: 2026-08-20. Estimate generated from public signals.

Portfolio saves

Added to 0 portfolios.

Portfolio saves do not represent ownership, equity, investment rights, IP rights, or affiliation.

Estimates are AI-generated from public information and are not financial advice or verified company valuations.